Pricing Pressures Intensify In Asia As Healthcare Budget Battles Rage On
This article was originally published in PharmAsia News
HONG KONG - Pharmacies and hospitals in the Philippines had until Tuesday to halve prices of a range of drugs or face the wrath of regulators keen to lower drug prices
You may also be interested in...
Taiwan may end a decade-long program of providing free AIDS drugs, citing rising costs as life expectancy grows.
SEOUL - Seoul's Administrative Court ruled in favor of Novartis and suspended the Korean health ministry's plan to cut the price of the Swiss-based company's leukemia drug Glivec (imatinib) by 14 percent beginning Sept. 15
SHANGHAI - As an important part of China's $850 billion healthcare reform plan, the Essential Drug List system will bring new challenges as well as opportunities for all players in China's drug supply chain